@article{17d97cea5d294ad2b8c773c1135a40cc,
title = "Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study",
keywords = "Colon cancer, Circulating tumor DNA, ctDNA, Adjuvant chemotherapy, TwiCs, RANDOMIZED CONTROLLED-TRIAL, CELL-FREE DNA, COLORECTAL-CANCER, RESIDUAL DISEASE, FLUOROURACIL, RECURRENCE, SURVIVAL, LEUCOVORIN, RISK, OXALIPLATIN",
author = "Schraa, {S. J.} and {van Rooijen}, {K. L.} and {van der Kruijssen}, {D. E. W.} and Alarcon, {C. Rubio} and J. Phallen and M. Sausen and J. Simmons and Coupe, {V. M. H.} and {van Grevenstein}, {W. M. U.} and S. Elias and Verkooijen, {H. M.} and Lacle, {M. M.} and Bosch, {L. J. W.} and {van den Broek}, D. and Meijer, {G. A.} and Velculescu, {V. E.} and Fijneman, {R. J. A.} and Vink, {G. R.} and M. Koopman and {van Iersel}, Liselot and {PLCRC-MEDOCC group}",
year = "2020",
month = aug,
day = "20",
doi = "10.1186/s12885-020-07252-y",
language = "English",
volume = "20",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central Ltd",
number = "1",
}